Walter U - Search Results

1

Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.

Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Walter U, et al. Neurology. 2003 Jan 14;60(1):74-7. doi: 10.1212/wnl.60.1.74. Neurology. 2003. PMID: 12525721 Clinical Trial.

2

Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.

Walter U, Wittstock M, Benecke R, Dressler D. Walter U, et al. J Neural Transm (Vienna). 2002 Feb;109(2):191-6. doi: 10.1007/s007020200015. J Neural Transm (Vienna). 2002. PMID: 12075859

3

[Anticoagulation in stroke. Evidence-based and empirical indications].

Walter U, Kloth A, Benecke R, Kunesch E. Walter U, et al. Dtsch Med Wochenschr. 2003 Oct 17;128(42):2200-5. doi: 10.1055/s-2003-42986. Dtsch Med Wochenschr. 2003. PMID: 14562219 Review. German. No abstract available.

4

Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.

Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R. Walter U, et al. Neurology. 2004 Aug 10;63(3):504-9. doi: 10.1212/01.wnl.0000133006.17909.32. Neurology. 2004. PMID: 15304582

5

Brain parenchyma sonography detects preclinical parkinsonism.

Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D. Walter U, et al. Mov Disord. 2004 Dec;19(12):1445-9. doi: 10.1002/mds.20232. Mov Disord. 2004. PMID: 15390070

6

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, Berg D. Hochstrasser H, et al. Among authors: walter u. Neurology. 2004 Nov 23;63(10):1912-7. doi: 10.1212/01.wnl.0000144276.29988.c3. Neurology. 2004. PMID: 15557511

7

Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.

Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D. Walter U, et al. Neurology. 2005 May 24;64(10):1726-32. doi: 10.1212/01.WNL.0000161847.46465.B9. Neurology. 2005. PMID: 15911799

8

Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease.

Schweitzer KJ, Hilker R, Walter U, Burghaus L, Berg D. Schweitzer KJ, et al. Among authors: walter u. Mov Disord. 2006 Jan;21(1):94-8. doi: 10.1002/mds.20669. Mov Disord. 2006. PMID: 16114024

9

Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.

Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R. Walter U, et al. J Neurol. 2006 Apr;253(4):448-54. doi: 10.1007/s00415-005-0023-9. Epub 2005 Nov 4. J Neurol. 2006. PMID: 16267638

10

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

Rolfs A, Böttcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Löhr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R. Rolfs A, et al. Among authors: walter u. Lancet. 2005 Nov 19;366(9499):1794-6. doi: 10.1016/S0140-6736(05)67635-0. Lancet. 2005. PMID: 16298216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

675 results

Search Page

Filters